[Federal Register Volume 61, Number 54 (Tuesday, March 19, 1996)]
[Notices]
[Pages 11215-11216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6585]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meeting

    Notice is hereby given of the meeting of the National Cancer 
Institute Board of Scientific Advisors Clinical Trials Working Group, 
April 8, 1996 at the Doubletree Hotel, 1750 Rockville Pike, Rockville, 
Maryland.
    This meeting will be open to the public on April 8, 1996 from 8:00 
am to 5:00 pm for overview and discussion of the Institute's Clinical 
Trials Extramural Program.
    The meeting will be closed to the public on April 8, 1996 from 5:15 
pm to adjournment for discussion of confidential issues relating to the 
review, discussion and evaluation of individual programs and projects 
conducted by the Clinical Trials Extramural Program. These discussions 
will reveal confidential trade secrets or commercial property such as 
patentable material, and personal information including consideration 
of personnel qualifications and performance, the

[[Page 11216]]
competence of individual investigators and similar matters, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Information pertaining to the meeting may be obtained from Dr. John 
Cole, III, Executive Secretary, National Cancer Institute Clinical 
Trials Working Group, National Cancer Institute, 6130 Executive Blvd., 
EPN, Rm. 540, Bethesda, MD 20892, (301-496-1718). Individuals who plan 
to attend and need special assistance such as sign language 
interpretation or other reasonable accommodations should contact Dr. 
John Cole, III in advance of the meeting.

    Dated: March 13, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-6585 Filed 3-18-95; 8:45 am]
BILLING CODE 4140-01-M